Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Institution Meets Magnet Designation by Incorporating ONS Standards in Care Delivery
    Oncology nurse influence
    Institution Meets Magnet Designation by Incorporating ONS Standards in Care Delivery
    October 19, 2018
    Brazil’s Inaugural Oncology Nursing Conference Reminiscent of ONS’s Own Beginnings
    Oncology nurse education
    Brazil’s Inaugural Oncology Nursing Conference Reminiscent of ONS’s Own Beginnings
    October 12, 2018
    How Patients Can Benefit From Hereditary Cancer Support
    Genetics & genomics
    How Patients Can Benefit From Hereditary Cancer Support
    September 18, 2018
    Oncology Nurse Educates Congressional Staff About the Importance of Palliative, Hospice Care
    Palliative care
    Oncology Nurse Educates Congressional Staff About the Importance of Palliative, Hospice Care
    September 11, 2018
    Oncology Nurses Must Share Experiences, Perspectives to Advocate for Change
    Health Policy
    Oncology Nurses Must Share Experiences, Perspectives to Advocate for Change
    August 28, 2018
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    ONS Member Featured in NCI Supportive and Palliative Care Research Video
    National Cancer Institute (NCI)

    ONS Member Featured in NCI Supportive and Palliative Care Research Video

    The National Cancer Institute (NCI) released a short video featuring ONS member Ann O’Mara, PhD, RN, MPH, program director in the NCI’s Division of Cancer Prevention. She speaks directly about research  projects focusing on supportive and palliative care for patients with cancer. O’Mara specifically highlights a recent study determining the impact of acupuncture on pain for patients with cancer.

    October 22, 2018
    CDC Spreads Breast Cancer Awareness
    Breast cancer

    CDC Spreads Breast Cancer Awareness

    October is Breast Cancer Awareness Month, and the Centers for Disease Control and Prevention (CDC) sent out a reminder to healthcare providers to share education and resources with their patients about breast cancer screening, detection, and prevention. CDC included a list for providers to highlight:

    • Breast cancer risk factors
    • Knowing what to do to lower those risks
    • When to get regular breast cancer screenings
    October 21, 2018
    NCI Releases Annual Strategic Plan and Budget Proposal
    National Cancer Institute (NCI)

    NCI Releases Annual Strategic Plan and Budget Proposal

    Every federal agency is required to submit a plan and proposal to Congress outlining its budget for the next fiscal year—or years—as well as justifications for how and why the department needs the requested allotment. In September 2018, the National Cancer Institute (NCI) released its Annual Plan and Budget Proposal for Fiscal Year 2020.

    October 20, 2018
    CMS Administrator Shares Three Points to Bolster Medicaid
    Health Policy

    CMS Administrator Shares Three Points to Bolster Medicaid

    During a recent speech at the 2018 Medicaid Management Care Summit, Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma expressed a continued commitment to Medicaid’s legacy of supporting Americans in need.

    October 17, 2018
    Moonshot Moves Forward Thanks to Biden Initiative
    Cancer moonshot

    Moonshot Moves Forward Thanks to Biden Initiative

    Like all great adventures, it began as an idea. What if the United States could make huge advancements in the fight against cancer in a short amount of time? How could that be accomplished? What are the metrics? How much would it cost? Who could direct such an effort? 

    September 19, 2018
    CMS Proposes Changes to Medicare and Doctor-Patient Relationships
    Health Policy

    CMS Proposes Changes to Medicare and Doctor-Patient Relationships

    One of the biggest challenges in medical practice is finding a way to spend enough time with each patient amid all the regulatory paperwork. To streamline workflows and encourage better provider-patient relationships, the Centers for Medicare and Medicaid Services (CMS) proposed new reforms to roll back certain regulatory efforts that were saddling clinicians with cumbersome paperwork. As part of those efforts, CMS reevaluated some of its reimbursement methods to improve efficiency with its required paperwork.

    September 13, 2018
    VA and NCI Collaborate on Access to Cancer Clinical Trials
    National Cancer Institute (NCI)

    VA and NCI Collaborate on Access to Cancer Clinical Trials

    A new cross-government program is underway to improve veterans’ access to clinical cancer trials. Together with the National Cancer Institute (NCI), the Department of Veterans Affairs (VA) Interagency Group to Accelerate Trials Enrollment launched in 12 VA facilities in summer 2018.

    September 12, 2018
    NIH Launches Study Focused on Prostate Cancer Rates in African American Men
    Prostate cancer

    NIH Launches Study Focused on Prostate Cancer Rates in African American Men

    To better understand environmental and genetic impacts associated with prostate cancer in African American men, the National Institutes of Health (NIH) began a new study, Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress (RESPOND). The research program has received more than $26 million in funding and seeks to understand why African American men have disproportionally higher rates of aggressive prostate cancer than any other racial or ethnic population.

    September 12, 2018
    CDC Offers Insights and Resources for Cancer Survivorship
    Survivorship

    CDC Offers Insights and Resources for Cancer Survivorship

    Cancer prevention is a full-time job, and the Centers for Disease Control and Prevention (CDC) works around the clock to raise awareness and promote necessary early detection and screening methods. Cancer survivors are a unique subset of patients and require information that’s been individualized to the survivorship experience.

    September 11, 2018
    FDA Commissioner Addresses Chronic Pain and Opioid Use
    Pain management

    FDA Commissioner Addresses Chronic Pain and Opioid Use

    As the opioid epidemic ravages American lives, every federal agency with an opportunity to review access is stepping up efforts to find appropriate lines between offering proper care and potentially enabling abuse. In a recent statement, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, acknowledged the challenge of balancing quality care efforts with overprescribing medications and the potential ease of access to opioids.

    September 11, 2018
    ONS Member Paice Shares Pain Management Policy Burdens With NCI
    Pain management

    ONS Member Paice Shares Pain Management Policy Burdens With NCI

    For the past two years, opioids have drawn the attention of researchers, members of Congress, the president, and the general public. With stories of drug abuse and heartbreaking tragedy, the problem with opioids in America has been dubbed an epidemic. Federal funding has accompanied the call to combat overdoses and adjust treatment plans to change the way addiction is dealt with from a medical perspective.

    August 30, 2018
    NINR Study Identifies Genes for Fatigue in Cancer Treatment
    Genetics & genomics

    NINR Study Identifies Genes for Fatigue in Cancer Treatment

    Radiation therapy can be an incredibly draining form of treatment for patients with cancer. Side effects such as fatigue can be debilitating for many before, during, and after treatment. Because symptom management is a crucial component to cancer care and central role of oncology nursing, ensuring that patients are able to mitigate their symptoms and side effects can help improve their quality of life. Recently, a team at the National Institute of Nursing Research (NINR) identified certain genes associated with fatigue in men being treated for prostate cancer.

    August 29, 2018
    HHS Secretary Directs FDA to Create Drug Importation Working Group
    U.S. Food and Drug Administration (FDA)

    HHS Secretary Directs FDA to Create Drug Importation Working Group

    The rising price of prescription drugs is an ongoing priority for the Trump administration. As part of the president’s blueprint to lower drug costs, the Department of Health and Human Services (HHS) secretary, Alex Azar, elevated the prescription cost issue throughout many federal agencies to help determine a new course of action.

    August 28, 2018
    Key Federal Health Policy Legislation Updates for 2018
    Health Policy

    Key Federal Health Policy Legislation Updates for 2018

    ’Tis the season. Well, at least in DC, it’s an exciting time. A political year. A long summer recess. A host of bills that are on the verge of passing. We are all aflutter with anticipation of the possibilities. But legislators need to remember who sent them to Washington and for what reason. Advocacy begins at home, and elected officials are heartened by what their constituents request, especially when that legislation is bipartisan and emotional and can affect people’s lives.

    August 01, 2018
    HHS Releases Blueprint for Affordable Prescription Drugs
    Prescription medication

    HHS Releases Blueprint for Affordable Prescription Drugs

    Health care is arguably the top domestic policy issue and of major concern to most Americans. Coverage, access, and, most importantly, affordability are not abstract political concepts discussed in elite coffeehouse circles but rather are real-world problems that people struggle with daily. Do I need to see a physician for this problem? What impact will a diagnosis have on my life? Can I afford the medication?

    July 17, 2018
    Health Policy Advances Cancer Treatment Options in the Era of Biosimilars
    Health Policy

    Health Policy Advances Cancer Treatment Options in the Era of Biosimilars

    Options and cost are a double-edged sword as biomedical research marches forward and the list of approved drugs expands. More targeted drugs for specific diseases means that more patients have treatment plans that can directly fight their specific disease, possibly resulting in cures.

    June 04, 2018
    ONS Greater Baltimore Chapter Advocates at the State Level
    Health Policy

    ONS Greater Baltimore Chapter Advocates at the State Level

    In today’s increasingly fractured political environment, with heightened partisanship, Washington, DC, has become toxic. New ideas and common-sense solutions are rare and promoting issues without politicization is literally a full-time job. Interest groups are now finding policy opportunities for success in the state capitals. Some advocacy initiatives have found easier, and faster, wins for their organizational efforts at the state legislature level.

    May 11, 2018
    Medicare Is Greater Than the Sum of Its Parts
    Health Policy

    Medicare Is Greater Than the Sum of Its Parts

    At the center of the President Lyndon B. Johnson’s great society was Medicare, a federal program designed as a partial safety net primarily for America’s older adults. It was signed into law on July 30, 1965. Controversial at the time, it is now sacrosanct and often referred to as the “third rail of politics”: touch it and die.

    April 10, 2018
    CDC Has New Director Designee
    Cancer health policy

    CDC Has New Director Designee

    Presidential appointees come, and presidential appointees go. Recently, the Center for Disease Control and Prevention’s (CDC’s) director resigned for financial conflicts of interest. The new Department of Health and Human Services (HHS) secretary, Alex Azar, sought to fill the important public health role as soon as possible. With opioids, the flu, vaccine shortages, and cancer prevention under the purview of the CDC, finding a new director was crucial to continuing the agency’s work. Since many of the CDC’s top officials are often reported on in the news, replacing the director was also essential for public trust in public health.

    April 03, 2018
    President’s Cancer Panel Reports on Drug Costs and Value
    Health Policy

    President’s Cancer Panel Reports on Drug Costs and Value

    Although it’s one of the less visible commissions, the President’s Cancer Panel monitors the activities of the National Cancer Program and reports on the burden of cancer. The panel reviews a number of topics and keeps current with demographic information and the latest cancer incidence research. After reviewing and recommending based on existing data, the panel releases a formal report to the president. In its most recent report, the panel found serious issues with barriers to access for cancer survivors, and it addressed the costs of drugs and the value therein.

    April 03, 2018
    FDA Authorizes Direct-to-Consumer Test for BRCA Cancer Gene
    U.S. Food and Drug Administration (FDA)

    FDA Authorizes Direct-to-Consumer Test for BRCA Cancer Gene

    Genetic testing is becoming more recognized among the general public, due in part to news reports and celebrity endorsements. Now, people are seeking to understand cancer risks and prevention measures through genetic information. There are many companies that ask for a mere mouth swab and deliver insight into a person’s DNA. As this becomes more commonplace, those with familial predisposition to cancer will look for ways to understand their own genetic results. Recently, the U.S. Food and Drug Administration (FDA) approved an at-home test identifying some—but not all—breast cancer genes.

    April 02, 2018
    NIA Promotes Smoking Cessation
    Cancer risk prevention

    NIA Promotes Smoking Cessation

    In a new message, the National Institutes of Health’s National Institute on Aging (NIA) division introduced a public health campaign concentrating on smoking cessation for senior citizens. The program elaborates on a central theme that says, “No matter your age, quitting smoking improves your health.” The agency lists the benefits of cessation, including the critical health impact that diseases have on those who continue to use tobacco.

    April 02, 2018
    CMS Releases Report on Oncology Care Model
    Quality Outcomes

    CMS Releases Report on Oncology Care Model

    The cost of cancer care and the quality of patient services has always been a top priority in health care. However, the Centers for Medicare & Medicaid Services (CMS) Innovation Center has been working to strengthen both elements of care. CMS, through its Oncology Care Model (OCM) division, works with cancer care providers to develop payment strategies and performance categories in treatment plans for patients with cancer.

    April 01, 2018
    National Agencies Recognize Oncology Nursing’s Role in Coordinated Patient Care
    Health Policy

    National Agencies Recognize Oncology Nursing’s Role in Coordinated Patient Care

    We live in the greatest age of scientific discovery and medical breakthroughs. Advances in the innovation and understanding of diseases are providing more insight into how we treat, and often cure, people with life-threatening illnesses. What was once deemed a death sentence diagnosis is now described as a chronic disorder, that can be handled with the help of the patient and a team of healthcare providers.

    March 15, 2018
    FDA Approves First Metastasis-Free Endpoint Treatment for Prostate Cancer
    U.S. Food and Drug Administration (FDA)

    FDA Approves First Metastasis-Free Endpoint Treatment for Prostate Cancer

    Breakthroughs and new treatments are moving faster than ever. Getting treatments approved by the U.S. Food and Drug Administration (FDA) is crucial whenever new options are making way to patients with cancer. In February 2018, the FDA approved apalutamide for the treatment of nonmetastatic prostate cancer that continues to grow despite treatment with hormone therapy, the first FDA-approved treatment for nonmetastatic, castration-resistant prostate cancer.

    March 08, 2018
    • Current page 1
    • Page 2
    • Page 3
    • Next page
    • Last page Last »
    Alec Stone ONS Public Affairs Director
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Terms of Use
  • Contact Us
  • Conferences
  • Advertising
  • Disclosures
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • ONS Foundation
  • ONCC
    • © Copyright 2018 Oncology Nursing Society
    Back to Top ▲